OSS, Netherlands, Nov. 14 /PRNewswire/ -- Asenapi

VIENNA, Austria, Oct. 17 /PRNewswire/ -- New data show that asenapine -- a psychopharmacologic agent being developed by Organon -- is effective in treating acute manic episodes associated with bipolar I disorder.

SAN FRANCISCO, Oct. 16 /PRNewswire/ -- Sugammadex

OSS, The Netherlands, August 1 /PRNewswire/ -- Or

By Julia Werdigier Schering-Plough, the American drug maker, agreed Monday to buy Akzo Nobel's Organon BioSciences unit for $14.4 billion in cash in a surprise move that spurred new takeover speculation in the industry.